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INTRODUCTION
Mammalian ES cells are derived from the inner cell mass of a
blastocyst (1). ES cells have the ability to self -renew and differen-
tiate into all three germ layers, namely, endoderm, mesoderm,
and ectoderm. Mouse ES cells can self -renew and maintain plu-
ripotency when cultured with LIF (2). It has been reported that
pluripotency-specific transcription factor network controls the plu-
ripotency of ES cells (3, 4). Moreover, the pluripotency of ES cells
could be attributed to the unique characteristics of the chromatin
in ES cells. For example, the chromatin in pluripotent stem cells
has an “open” structure, which is characterized by the enrichment
of active histone marks such as acetylation and methylation in a
particular region ; in contrast, differentiated cells have relatively
“compact” chromatin (5). This property is considered important
for the maintenance of adequate gene expression necessary for
pluripotency.
Recent reports have indicated that energy metabolism plays an
important role in the regulation of stem cell characteristics (6).
Pluripotent stem cells are mainly dependent on glycolysis, while
differentiated cells, like fibroblasts, rely on mitochondrial respi-
ration (7). Therefore, ES cell differentiation is characterized by a
dramatic shift in metabolic pathways, from anaerobic glycolysis to
aerobic mitochondrial respiration. Of greater interest is the report
by Zhou et al. , which states that mouse ES cells and human ES
cells are metabolically different. The latter cell type, which is simi-
lar to the epiblast stem cell (EpiSC) established from later -stage
post- implantation epiblasts, is exclusively glycolytic, as opposed
to a naïve pluripotent cell type, mouse ES cell, which is dependent
on both glycolytic and mitochondrial respiration (8). This obser-
vation raises a possibility that not only transcriptional network but
also metabolic pathway is important for the control of stem cell
pluripotency.
In this study, we performed proteome analysis to explore the
novel mechanisms underlying the maintenance of pluripotency in
ES cells. For this purpose, 2D-DIGE was used to identify the dif-
ferentially expressed proteins between two samples by comparing
the intensities of differentially dye- labeled protein spots separated
on a gel. We have identified several novel proteins that were highly
expressed in pluripotent ES cells. Here, we discuss the manner
in which these proteins are possibly involved in the pluripotency
of ES cells.
MATERIALS AND METHODS
Cell culture
Mouse ES cell line D3 was purchased from ATCC (American
Type Culture Collection). In order to maintain their pluripotency,
ES cells were cultured on mitomycin-C-treated mouse embryonic
fibroblast (MEF) feeder cells in Dulbecco’s Modified Eagle’s Me-
dium with high glucose (Gibco, Grand Island, NY, USA), 15% heat-
inactivated ES-qualified FCS (Gibco), 1non-essential amino acids
(Sigma-Aldrich, St. Louis, MO, USA), 0.1 mM 2-mercaptoethanol
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(Wako Pure Chemical Industries, Osaka, Japan), 0.1 mg/ml penicil-
lin/streptomycin (Gibco) and 1,000 U/ml LIF (ESGRO ; Chemicon
International, Inc, Temecula, CA, USA) under 5% CO2 at 37. For
the preparation of chromatin-associated proteins, ES cells were
cultured on gelatin-coated plates without MEFs in the presence or
absence of LIF for 7 days.
Measurement of alkaline phosphatase activity
The ES cells cultured with or without LIF for 7 days were washed
twice with phosphate buffered saline (PBS) and fixed in 3.7% for-
maldehyde/PBS for 10 min at room temperature (r.t.). The cells
were then washed twice with PBS and incubated with BM purple
AP substrate (Roche, Mannheim, Germany) for 30 min at r.t.
Preparation of protein samples
The ES cells cultured in the presence or absence of LIF were
treated with 0.06 μg/ml colcemid (Wako) for 12 h before harvest-
ing. They were then scraped from the dishes in polyamine buffer
(15 mM Tris-HCl [pH 7.4], 0.2 mM spermine, 0.5 mM spermidine,
2 mM EDTA, 80 mM KCl, 0.1 mM phenylmethylsulfonyl fluoride)
followed by centrifugation at 780g for 10 min at 4. Subsequently,
the cells were resuspended in the polyamine buffer supplemented
with 0.1% (w/v) digitonin, and the cell membrane was destroyed
by vortexing. After centrifugation at 190g for 3 min at 4, the
supernatant was collected as a crude chromatin fraction. The crude
sample was purified by sucrose density -gradient centrifugation.
Briefly, the sample was gently layered on the density gradient tube
with a sucrose gradient generated by gradually mixing 5% and
20% sucrose in the polyamine buffer by using a peristaltic pump,
followed by centrifugation at 2,380g for 15 min at 4. The puri-
fied chromatin fraction was then treated using a nucleic acid affinity
column (Vivapure D Maxi H ; Vivascience, Hannover, Germany)
according to the manufacturer’s protocol and desalted by centrifu-
gation with Amicon ultra-15 (NMWL 10ka ; Millipore, Billerica,
MA, USA) at 2,580g for 90 min at 4 three times in 7 M urea
buffer (30 mM Tris-HCl [pH 8.5], 7 M urea, 2 M thiourea, and 4%
CHAPS). The purified protein sample was subjected to 2D-DIGE
or further purified by removal of DNA and RNA by enzymatic di-
gestion and desalting with ultrafiltration. Briefly, 1 ml of the protein
sample was mixed with 10 μl Nuclease Mix (GE Healthcare Bi-
oSciences, Piscataway, NJ, USA) and incubated for 45 min at r.t.
followed by centrifugation as described above.
Western blotting
The protein sample was lysed in a lysis buffer (20 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM
Na3VO4, 25 mM NaF, and 25 mM β -glycerophosphate) supple-
mented with a protease inhibitor cocktail (complete ; Roche), and
rotated for 1 h at 4. After centrifugation at 17,000g for 10 min
at 4, the supernatants were collected and their protein concen-
trations were determined using the Bradford protein assay kit
(Bio-Rad Laboratories, Hercules, CA, USA). Subsequently, 10 μg
of protein extract was resolved by sodium dodecyl sulfate -poly-
acrylamide gel electrophoresis (SDS-PAGE) and transferred to
polyvinylidene fluoride membranes. The membranes were blocked
with 5% non-fat skim milk in TBS/Tween-20 (10 mM Tris-HCl
[pH 7.4], 150 mM NaCl, and 0.1% Tween-20) and incubated over-
night with a primary antibody at 4. After incubation with a horse-
radish peroxidase-conjugated secondary antibody, the blots were
incubated with an enhanced chemiluminescent assay reagent (Su-
perSignal West Femto ; Pierce Biotechnology, Rockford, IL, USA)
for 5 min at r.t., and the protein bands were visualized using a
LAS-1000 lumino- image analyzer (Fuji Film, Tokyo, Japan). The
antibodies used for western blotting were as follows : Nanog
(RCAB0001P ; ReproCELL, Yokohama, Japan), Oct-3/4 (sc-9081 ;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), Histone H3
(ab1791 ; abcam, Cambridge, MA, USA), FBL (ab4566 ; abcam),
α - tubulin (T9026 ; Sigma-Aldrich), PHB1 (3805-100 ; BioVision,
Milpitas, CA, USA), and PHB2 (sc-133094 ; Santa Cruz).
2D-DIGE
2D-DIGE was performed using Ettan DIGE (GE Healthcare
BioSciences). Briefly, the protein samples were dissolved in 2D-
DIGE sample buffer (30 mM Tris-HCl [pH 8.5], 7 M urea, 2 M
thiourea, and 4% CHAPS), and the amount of protein was measured
by Bradford protein assay kit (Bio-Rad). Approximately 50 μg of
chromatin-binding proteins extracted from pluripotent ES cells
were labeled with Cy3, while those from differentiated cells were
labeled with Cy5, according to the manufacturer’s protocol (GE
Healthcare BioSciences). The fluorescent- labeled proteins with
different colors were mixed and subjected to isoelectric focusing.
Immobiline dry strips (pH : 3-11, linear, 24 cm) (GE Healthcare
BioSciences) were rehydrated for 12 h at r.t. before isoelectric
focusing for a total of 65 kVh with a Multiphor II apparatus. The
second dimension was performed under a standard SDS-PAGE
protocol using 12% (w/v) polyacrylamide gels. The gels were
scanned using a Typhoon 9400 fluorescent scanner (GE Health-
care BioSciences) and analyzed using ImageMaster DIGE software
(GE Healthcare BioSciences).
Protein identification by peptide mass fingerprinting
After electrophoresis, the gel was stained with Deep Purple
(GE Healthcare BioSciences), and the images of protein spots were
captured with the Typhoon 9400 scanner. The preparative gel image
was matched to the master gel image in the analytical gel by using
the DeCyder software (GE Healthcare BioSciences). The protein
spots were picked up by Ettan Spot Picker (GE Healthcare Bi-
oSciences), an automated spot handling system. In-gel digestion
was performed as follows. The gel plugs were washed with 50 mM
ammonium bicarbonate containing 50% (v/v) acetonitrile, followed
by washing with 100% (v/v) acetonitrile for dehydration, and dried
completely in a SpeedVac evaporator. Following overnight diges-
tion with trypsin (Promega, Fitchburg, WI, USA) at 37, pep-
tides were extracted twice with 66% (v/v) acetonitrile in 0.1% (v/v)
trifluoroacetic acid. The extracted peptides were desalted using a
ZipTip C18 column (Millipore) according to the manufacturer’s
protocol, and analyzed using a Micromass Q-Tof Mass Spectrome-
ter (Waters Corp., Milford, MA, USA). Peptide mass fingerprints
were analyzed using the Mascot software (Matrix Science Ltd.,
London, UK).
Immunofluorescent staining
Mouse ES cells were washed with PBS, fixed in 3.7% formalde-
hyde in PBS for 30 min at r.t., and then permeabilized with 0.5%
Triton X-100 in PBS for 5 min at r.t. The cells were blocked with
5% FCS in PBS for 1 h at r.t., and incubated with primary antibod-
ies. After washing 3 times with 5% FCS in PBS, the cells were in-
cubated with fluorescently labeled secondary antibodies for 1 h at
r.t., and cell nuclei were stained with 4,6 -diamidino-2-phenylindole
(Vector Laboratories, Burlingame, CA, USA). The cells were ob-
served under a fluorescence microscope (IX70 ; Olympus, Tokyo,
Japan) equipped with CoolSNAP HQ2 (Photometrics, Tucson,
AZ, USA) and images were processed using MetaMorph software
(Molecular Devices, Sunnyvale, CA, USA). A confocal fluorescence
microscope (FV1000 ; Olympus) was also used to analyze the cells.
The antibodies used for the immunofluorescent staining were as
follows : FBL (ab4566 ; abcam) and Nucleolin (ab70493 ; abcam).
Plasmid construction
Plasmids were constructed as previously described (9, 10). Briefly,
the full - length coding regions of FBL and PHB2 (Flag-tagged at
the C-terminus) were amplified by polymerase chain reaction
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(PCR) and inserted into the pCAG-IP vector (11) or pPthC vector
(12), respectively. FBL-expressing ES cell lines were established
as follows : ES cells were transfected with pCAG-IP-FBL vector by
using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA),
and the cells stably expressing FBL were selected in the pres-
ence of 0.4 μg/ml puromycin. Tetracycline (Tc)-regulated PHB2-
expressing ES cell lines were established according to the method
of Masui et al. (12). An EB3 cell -derived mouse ES cell line,
EBRTcH3, which contained a Tet-off cassette in the ROSA26 locus
(12), was co-transfected with a targeting vector, pPthC-PHB2-Flag
and a Cre recombinase expressing vector, pCAGGS-Cre, using
Lipofectamine 2000 (Life Technologies) and cultured in the pres-
ence of 1.5 μg/ml puromycin and 1 μg/ml Tc.
RESULTS
Preparation of pluripotent ES cells and differentiated cells
Initially, we explored the novel chromatin-associated proteins,
which are highly expressed in pluripotent ES cells. Mouse ES cells
were cultured under feeder- free conditions to avoid contamination
by feeder cell -derived proteins. The pluripotency of ES cells was
confirmed by monitoring alkaline phosphatase activity (13). After
7 days of culture without feeder cells, ES cells cultured without LIF
almost completely lost their alkaline phosphatase activity, while
the cells with LIF still maintained the strong activity (Fig. 1A). In
addition, ES cells cultured with LIF exhibited a colony- like shape
similar to that exhibited by pluripotent ES cells cultured on the
feeder cells with LIF, indicating maintenance of pluripotency. There-
fore, we defined the cells cultured for 7 days without LIF as “dif-
ferentiated cells” and those cultured with LIF as “pluripotent ES
cells” and prepared chromatin-associated proteins from each group.
Analysis of pluripotent markers on protein samples
The protein level of pluripotent markers Nanog and Oct-3/4 was
analyzed with purified chromatin-associated protein samples. West-
ern blotting analysis showed that both Nanog and Oct-3/4 were
significantly down-regulated in the differentiated state, while the
control Histone H3 protein did not show any difference between the
two states (Fig. 1B). This result indicated successful completion of
protein fractionation, with protein expression profile specific to each
state. These protein samples were labeled with Cy3 (pluripotent
ES cells) or Cy5 (differentiated cells) and analyzed by 2D-DIGE.
Identification of differentially expressed proteins between pluri-
potent ES cells and differentiated cells
Protein samples were separated in the isoelectric point (pI) range
of 3.0 -11.0 by isoelectric focusing followed by SDS-PAGE using
12% (w/v) polyacrylamide gels. As shown in Fig. 2, we selected
more than 70 protein spots differentially expressed between two
samples, and finally identified 39 differentially expressed protein
spots (29 independent proteins) by mass spectrometry. However,
most of the proteins distributed in the high pI range, i.e. basic pro-
teins, were not well separated. Considering that chromatin is com-
posed of DNA and DNA-binding proteins, majority of the chromatin-
associated proteins are supposed to be basic proteins. Therefore,
we further purified these proteins by treatment with nucleases to
remove DNA and RNA that could hamper the separation of pro-
teins by electrophoresis. These purified samples were then sub-
jected to 2D-DIGE with the pI range of 7.0 -11.0. The resulting elec-
trophoresis successfully resolved many basic proteins. More than
30 differentially expressed protein spots were selected, and mass
spectrometry identified additional 21 spots (15 independent proteins)
as the differentially expressed proteins (Fig. 3). Surprisingly, ma-
jority of these differentially expressed proteins in the chromatin-
associated protein fraction were known to localize in other organ-
elles, such as mitochondrion (Table I, II).
Fig. 2. 2D-DIGE of chromatin -binding proteins fractionated from pluripotent ES cells and differentiated cells. These proteins were separated
in the pI range of 3.0 -11.0. Only the differentially expressed protein spots identified by mass spectrometry were numbered. The region circled
by orange dashed line was analyzed in Fig. 3.
Fig. 1. Expression of pluripotency-specific markers in cells used for
proteomic analysis. (A) Alkaline phosphatase activity in mouse ES cells
cultured in the presence or absence of LIF for 7 days. Cells with alkaline
phosphatase activity are stained in blue. (B) Western blotting analysis of
chromatin -binding proteins extracted from mouse ES cells cultured in
the presence or absence of LIF for 7 days. MEF : mouse embryonic feeder
cells.
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Fig. 3. 2D-DIGE of chromatin -binding proteins in the alkaline pH range. Proteins fractionated from pluripotent ES cells and differentiated cells
were further purified with removal of nucleotides by enzymatic digestion, and separated by 2D-PAGE in the pI range of 7.0 -11.0. Only the differ-
entially expressed protein spots identified by mass spectrometry were numbered.
Table. The list of proteins identified with the first 2D-DIGE (pI range : 3.0 -11.0).
Spot No. Ratio (+LIF/-LIF) Protein name Localization pI MW
62 2.89 Manganese superoxide dismutase M 8.8 24662
54 2.64 Adenylate kinase 4 M 7.02 25046
38 1.82 Inner membrane protein, mitochondrial M 6.18 83848
64 1.81 Ubiquinol cytochrome c reductase core protein 2 M 9.26 48205
3 1.79 NADH dehydrogenase (ubiquinone) Fe-S protein 1 M 5.51 79698
47 1.76 Voltage-dependent anion channel 2 M 7.44 31713
50 1.75 Pyrroline -5-carboxylate reductase 1 M 6.36 32353
39 1.73 Fragile -X-related protein 1 isoform c N, Cy 5.93 72770
4 1.7 NADH dehydrogenase (ubiquinone) Fe-S protein 1 M 5.51 79698
5 1.69 NADH dehydrogenase (ubiquinone) Fe-S protein 1 M 5.51 79698
61 1.67 Ptrh2 protein Cy, M 6.96 19514
36 1.66 TNF receptor -associated protein 1 M 6.25 80027
40 1.64 TNF receptor -associated protein 1 M 6.25 80027
27 1.62 NADH dehydrogenase (ubiquinone) Fe-S protein 8 M 5.89 23996
45 1.61 Stomatin - like protein 2 Cy, M 8.95 38361
52 1.6 SCO cytochrome oxidase deficient homolog 1 M 8.66 32098
33 1.6 Mitochondrial ribosomal protein L46 M 6.93 32112
6 1.58 NADH dehydrogenase (ubiquinone) Fe-S protein 1 M 5.51 79698
43 1.56 Glycerol -3-phosphate dehydrogenase 2 M 6.26 80932
28 1.52 Prohibitin N, M 5.57 29802
70 1.52 Fibrillarin N 10.25 34286
10 1.52 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide M 5.24 56632
59 1.52 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 M 9.22 59716
58 1.51 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 M 9.22 59716
57 1.5 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 M 9.22 59716
13 -1.51 Tropomyosin 3, gamma Cs 4.73 33129
65 -1.57 Proteasome 26S non-ATPase subunit 13 N, Cy 5.46 42782
25 -1.66 Actin, gamma 1 Cs 5.31 41766
66 -1.68 Actin, beta 1 Cs 5.78 39161
14 -1.71 RIKEN cDNA 2900073G15 ‐ 4.76 19883
22 -1.84 Actin, gamma 1 Cs 5.56 40992
26 -2.19 Lamin B N 5.14 66719
8 -2.54 Vimentin Cs 5.06 53655
44 -2.71 Caldesmon 1 Cy 6.97 60417
46 -2.97 Calcium-binding transporter M 7.02 52868
41 -4.02 Caldesmon 1 Cy 6.97 60417
15 -4.6 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide M 5.24 56632
11 -5.47 Actin, beta 1 Cs 5.78 39161
12 -8.26 Alpha tropomyosin Cs 4.69 32661
N : nucleus, M : mitochondrion, Cy : cytoplasm, Cs : cytoskeleton
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Validation of identified proteins
Despite the unexpected results, we conducted a western blotting,
in order to confirm the differential expression of the identified pro-
teins. Among these proteins, Fibrillarin (FBL) was confirmed to be
more highly expressed in pluripotent ES cells than in differenti-
ated cells (Fig. 4A). FBL is known to localize in the nucleolus, and
functions as a core subunit of small nucleolar ribonucleoprotein
(snoRNP), which dynamically regulates protein synthesis and cell
proliferation through ribosomal RNA (rRNA) biosynthesis (14).
Immunofluorescent staining of FBL further confirmed a significant
decrease of FBL protein in the nucleoli and this was associated
with nucleolar morphology. Specifically, pluripotent ES cells with
high FBL expression contained one or two large nucleoli while
differentiated cells with lower FBL expression contained fragmented
nucleoli, suggesting the possibility that FBL regulates nucleolar
functions in the pluripotent ES cells (Fig. 4B). We therefore es-
tablished a FBL-overexpressing ES cell line for further analysis.
ES cells transfected with a control vector lost their pluripotency
when cultured without LIF for 7 days. In contrast, the FBL-over-
expressing ES cells maintained alkaline phosphatase activity even
after the removal of LIF (Fig. 4C). These results suggested that
FBL highly expressed in pluripotent ES cells has a positive effect
on the maintenance of the undifferentiated state of ES cells.
We also confirmed high expression levels of mitochondrial mem-
brane proteins Prohibitins (PHBs), which are involved in mito-
chondrial biogenesis and metabolism. The expression of PHBs
was down-regulated in differentiated cells. Especially, PHB2 was
much more decreased than PHB1 (Fig. 5A). To further investigate
the regulatory effect of PHB2, we established a PHB2-overexpress-
ing ES cell line. This cell line showed high alkaline phosphatase
activity after 7 days of culture without LIF (Fig. 5B), suggesting
that PHB2 could also positively regulate the maintenance of plu-
ripotency in ES cells.
DISCUSSION
In this study, we identified 44 proteins that are differentially
expressed between pluripotent ES cells and differentiated cells.
Some of these proteins are considered to be collateral evidence
Table. The list of proteins identified with the second 2D-DIGE (pI range : 7.0 -11.0).
Spot No. Ratio (+LIF/-LIF) Protein name Localization pI MW
84 2.42 4-nitrophenylphosphatase domain and non-neuronal SNAP25- like protein homolog 1 M 9.48 33342
73 1.6 Programmed cell death 8 N, M 9.23 66724
75 1.51 Voltage-dependent anion channel 1 Cy, M 8.62 30737
77 1.48 Voltage-dependent anion-selective channel protein 1 Cy, M 8.55 32331
72 1.45 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 N, M 9.22 59716
91 1.42 Ubiquinol -cytochrome c reductase binding protein M 9.1 13553
96 1.4 Coiled-coil -helix -coiled-coil -helix domain containing 3 N, Cy, M 8.56 26318
82 1.38 Polyadenylate -binding protein 1 N, Cy 9.52 70598
85 1.36 Peptidyl -prolyl cis - trans isomerase B precursor Extr 9.56 22699
83 1.26 Prohibitin 2 N, M 9.83 33276
81 -1.23 ATP-dependent RNA helicase DDX5 N 8.88 74579
78 -1.33 Chromosome condensation 1 N 8.34 44903
90 -1.34 Protease, serine, 1 Extr 4.75 26118
76 -1.41 Protease, serine, 1 Extr 4.75 26118
80 -1.42 ATP-dependent RNA helicase DDX5 N 9.06 69277
97 -1.43 Insulin - like growth factor 2, binding protein 1 N, Cy 9.26 63411
87 -1.43 Ribosomal protein S17 Cy 9.85 15383
99 -1.46 Ribonucleoprotein heterogeneous nuclear ribonucleoprotein A3 N, Cy 8.46 37063
88 -1.59 Ribosomal protein S17 Cy 9.85 15383
86 -1.62 Protease, serine, 1 Extr 4.75 26118
100 -1.69 Ribonucleoprotein heterogeneous nuclear ribonucleoprotein A3 N, Cy 8.46 37063
N : nucleus, M : mitochondrion, Cy : cytoplasm, Extr : extracellular matrix
Fig. 4. The expression of FBL in pluripotent ES cells. (A) Proteins
extracted from mouse ES cells cultured in the presence or absence of LIF
for 7 days were analyzed by western blotting. (B) The subcellular localiza-
tion of nucleolar proteins were analyzed by immunofluorescent staining.
(C) Alkaline phosphatase activity in the control vector - transfected cells
(mock) and FBL-overexpressing cells cultured in the presence or ab-
sence of LIF for 7 days was analyzed. Cells with alkaline phosphatase
activity were stained in blue.
Fig. 5. The expression of PHB2 in pluripotent ES cells. (A) Proteins
extracted from mouse ES cells cultured in the presence or absence of LIF
for 7 days were analyzed by western blotting. (B) Alkaline phosphatase
activity in the control vector - transfected cells (mock) and PHB2-over-
expressing cells cultured in the absence of LIF for 7 days was analyzed.
Cells with alkaline phosphatase activity were stained in blue.
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of appropriate purification of the chromatin fractions as they are
indicative of the properties maintained in cells in either state. One
such protein is Lamin B1 (LMNB1), which is a major component
of the interior structure of the nuclear envelope and regulates gene
expression by interacting with chromatin (15). In this study, we
observed increased LMNB1 levels in the differentiated cells. This
is consistent with a previous report that showed a more robust
interaction of LMNB1 with chromatin in differentiated cells than
with chromatin in pluripotent ES cells (16). This phenomenon
could be attributed to the detection of a greater amount of LMNB1
in the chromatin purified from differentiated cells.
We further investigated the possible functions of the identified
proteins, and found that some proteins play significant roles in
the maintenance of pluripotency in ES cells. One such example is
FBL. We identified FBL as a protein that is up-regulated in pluri-
potent ES cells. Stable expression of FBL resulted in prolonged
pluripotency after removal of LIF from culture medium. Moreover,
FBL has a positive effect on the maintenance of pluripotency (Fig.
4C). In addition, we recently revealed that FBL inhibits neuronal
differentiation of ES cells by controlling rRNA synthesis in a p53-
dependent manner (9). These results suggested that proper rRNA
production in nucleoli, which is responsible for dynamic regulation
of protein synthesis and cell proliferation, may represent a novel
factor that regulates pluripotency and differentiation of ES cells.
Despite the purification of chromatin-associated proteins, a con-
siderable number of mitochondrial proteins were also identified.
This phenomenon may be attributedto the technical difficulty caused
by the high copy number of mitochondria associated with con-
densed chromosomes during mitosis. Similar observations were
reported in a previous study (17). In this previous report, mitochon-
drial proteins identified from a purified chromosome-associated
fraction were referred to as “chromosome coating proteins” (17).
Regardless of the physical coupling between the mitochondria
and the nucleus, some mitochondrial proteins change their loca-
tions depending on the circumstances, and play important roles in
the nucleus. In fact, some of the mitochondrial proteins identified
in this study were demonstrated to have important functions in ES
cells. For instance, programmed cell death protein 8, also known
as apoptosis- inducing factor, mitochondrion-associated 1 (AIFM1),
was identified to be highly expressed in pluripotent ES cells. It
has been reported that AIFM1 is an apoptosis- inducing factor that
localizes in mitochondria ; however, it translocates to the nucleus
in response to stimuli and triggers cell death, which is indispen-
sable for the early development of mouse embryo (18).
Other examples of the identified mitochondrial proteins highly
expressed in pluripotent ES cells are PHBs. PHB1 and PHB2 have
homologous amino acid sequences (more than 50% identity) and
assemble into a heterodimer complex to form a ring- like structure
in the inner membrane of mitochondria (19). PHBs are also known
to localize in multiple intracellular compartments other than mi-
tochondria and have multiple functions. They not only act as chap-
erones in the inner membranes of mitochondria, but also regulate
gene expression by interacting with transcription factors in the
nucleus (20). Apart from the cooperative function mentioned above,
PHB1 and PHB2 have also been reported to have independent
functions. For example, Heron et al. reported that PHB2 affects
the regulation of skeletal muscle differentiation by binding to Akt2,
but PHB1 does not (21).
In a mass spectrometry analysis, PHB1 showed a higher +LIF/-
LIF expression ratio than PHB2 ; however, western blot analysis
revealed that PHB2 expression changes more dynamically between
pluripotent ES cells and differentiated cells than PHB1 expression
(Table I, II, and Fig. 5A). Therefore, we focused our further analy-
ses on PHB2. The PHB2-overexpressing ES cells cultured in the
absence of LIF showed prolonged pluripotency similar to that
shown by FBL-overexpressing ES cells (Fig. 5B). Indeed, a recent
study from our group showed that PHB2 is mainly localized in
mitochondria and indispensable for the maintenance of pluripotency
in mouse ES cells (10). Moreover, PHB2 is essential for ATP syn-
thesis and overexpression of PHB2 inhibited the differentiation of
ES cells into neural and endodermal lineages. These data suggest
that PHB2 is a crucial mitochondrial regulator for homeostasis and
lineage-specific differentiation of ES cells. There might be other
mitochondrial proteins in the list of identified proteins that regu-
late pluripotent stem cells, though their functions have yet to be
defined.
In summary, we identified numerous proteins that are differ-
entially expressed between pluripotent and differentiated states.
Moreover, we validated that at least two of these proteins, FBL
and PHB2, which are involved in the metabolic regulation such
as rRNA biosynthesis and mitochondrial energy production, are
novel regulatory proteins of pluripotency in ES cells. Further vali-
dation of the identified proteins in pluripotent ES cells could shed
new light on the mechanisms underlying the maintenance of plu-
ripotency, and contribute to future regenerative medicine and drug
development using pluripotent stem cells.
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